TB Research

Cognitive impairment in patients with central nervous system tuberculosis

Ignacio Popoca-Rodríguez, Graciela Cárdenas

Gaceta Médica de México · 2022-01

Abstract

INTRODUCTION: Tuberculosis (TB) in Mexico remains an important cause of morbidity and mortality; in the past 4 years, 110,681 cases of pulmonary tuberculosis and 1571 cases of tuberculous meningitis were reported. OBJECTIVE: To determine the neurocognitive sequelae, clinical presentation and neuroimaging alterations in patients with central nervous system tuberculosis. METHODS: A retrospective, analytical, and cross-sectional study was carried out from 2010 to 2019. Patients with central nervous system tuberculosis, with and without HIV/AIDS coinfection, were included. RESULTS: During the study period, 104 cases with a definitive or probable central nervous system tuberculosis diagnosis were included; 38% had HIV/AIDS coinfection, and 55%, various comorbidities (p = 0.0001); 49% had cognitive alterations, and 14% died. CONCLUSIONS: Although HIV/AIDS infection can contribute to cognitive decline in patients with tuberculous meningitis, no differences were observed between patients with and without HIV/AIDS. Cognitive sequelae showed improvement during follow-up with adequate management and therapeutic control of the patients.

MeSH terms

  • Medicine
  • Tuberculosis
  • Coinfection
  • Neurocognitive
  • Pediatrics
  • Tuberculous meningitis
  • Meningitis
  • Central nervous system
  • Retrospective cohort study
  • Human immunodeficiency virus (HIV)
  • Surgery